Home > Healthcare > Pharmaceuticals > Finished Drug Form > Sleep Medications Market
Sleep Medications Market Share
- Report ID: GMI6681
- Published Date: Sep 2023
- Report Format: PDF
Sleep Medications Market Share
The prominent players in sleep medications market include:
- Pfizer Inc.
- Sanofi SA
- Eisai Co., Ltd.
- Sunovion Pharmaceuticals Inc.
- Merck and Co Inc.
- Takeda Pharmaceutical Company Limited
- Johnson & Johnson
- Novartis A
- Vanda Pharmaceuticals
- Teva Pharmaceuticals.
Frequently Asked Questions (FAQ) :
Global market size for sleep medications was USD 21.5 billion in 2023 and will register 6.8% CAGR from 2024-2032 due to the increasing prevalence of sleep disorders and stressful lifestyle of consumers worldwide.
The prescription-based drugs segment held 71.3% share of the sleep medications market in 2022 on account their targeted effectiveness and the growing capacity of healthcare professionals to customize treatment.
North America industry may reach USD 15.3 billion by 2032 owing to the prevalence of fast-paced and high-stress lifestyles in the region.
Pfizer Inc. Sanofi SA Eisai Co., Ltd., Sunovion Pharmaceuticals Inc., Merck and Co Inc., Takeda Pharmaceutical Company Limited, Johnson & Johnson, Novartis AG, Vanda Pharmaceuticals, and Teva Pharmaceuticals are some of the major sleep medications companies worldwide.
Sleep Medications Market Scope
×
Get a free sample of
Sleep Medications Market
Inquiry Before Buying
Get special pricing options on this report
Request Sectional Data
Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours
below